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For more than 30 years, the ﬂuorescence-based technique of
ﬂow cytometry (FCM) has been widely used by clinicians,
immunologists, and cancer biologists to distinguish diﬀerent
cell types in mixed cell subpopulations, based on the
expression of cellular markers. In both health research and
treatment, this analytical method is used for a variety of
tasks, in particular the diagnosis and monitoring of cancer.
This technology is also used for cross-matching organs for
transplantation,andforresearchinvolvingstemcells,vaccine
development, apoptosis and phagocytosis.
In the last decade, advances in FCM instrumentation
and reagent technologies have enabled simultaneous single
cell measurement of surface and intracellular markers,
includingcellular-activationmarkers,intracellularcytokines,
immunological signaling, and cytoplasmic and nuclear cell
cycle and transcription factors, thus positioning FCM to play
an even bigger role in health care and medical research.
However, the rapid expansion of FCM applications has
outpaced the development of tools for storage, analysis, and
data representation. For example, a typical FCM experiment
may involve measurement of up to 20 diﬀerent charac-
teristics per cell, for hundreds of thousands of cells per
sample. The increase in the amount of data generated by
FCM techniques poses unique informatics and statistical
challenges.
It is widely recognized that one basic challenge for
FCM is to simplify the extraction of data and statistical
information. To date, very few bioinformatic and statistical
tools exist to manage, analyze, present, and disseminate
FCM data. Current FCM data analysis methods involve
the use of multiple applications, the output of which is
often fragmented. There is a widespread demand for the
development of integrated data analysis tools to organize,
analyze, and exchange FCM data. Such development is
lagging far behind the ability to collect and process samples
via FCM, much to the detriment of health research.
This special issue aims to summarize the current state of
bioinformatics research in FCM, to present the most recent
developments in analytical tools and to open-up the ﬁeld
to new researchers to bring additional ideas and solutions
to current bottlenecks. The issue includes several important
contributions, which cover a wide range of approaches and
techniques for FCM. These contributions are summarized as
follows.
Bashashati and Brinkman review state-of-the-art FCM
data analysisapproachesthat can be used in a typical analysis
pipeline going from quality assessment to sample classiﬁca-
tion. Not only does their paper review current techniques
and approaches but it also points out potential pitfalls of
these approaches and discusses strategies to overcome these.
Much like with gene expression data, technical variation
such as changes in the instrumentation channel voltages
or changes in the speciﬁcity of the manufacturer of the
antibodies can result in systematic biases. These biases need2 Advances in Bioinformatics
to be removed or at least minimized in order to allow proper
dataanalysisandsamplecomparisons.Cichockietal.present
a novel normalization method to correct for time biases
in large-scale ﬂow cytometric analysis. They investigate two
types of normalizing beads: broad spectrum and spectrum
matched and propose two alternative normalization proce-
dures that are usable in the absence of normalizing beads.
Once data have been properly normalized, a component
of FCM analysis involves identifying immunophenotypically
distinct sub-populations of cells within each patient; this is
referred to as “gating” in the FCM community. Although
gating has traditionally been done visually, automated
approaches based on statistical modeling of the data are
starting to emerge. Walther et al. present such an approach
based on a nonparametric statistical model that aims to form
cell subpopulations that can be delineated by the contours
of high-density regions much like in manual gating. Because
their approach is non-parametric it can reproduce non-
convex subpopulations that are known to occur in FCM
samples, but which cannot be produced with current para-
metric model-based approaches. Much like Walther et al.,
Finak et al. present a framework for the identiﬁcation of
cell subpopulations in FCM data based on merging mixture
components using the ﬂowClust methodology. In this new
approach, several parametric clusters can represent a single
sub-population, and the approach can thus accommodate
complicated FCM data distributions (e.g., non-convex sub-
populations).
Even though automated gating methods are becoming
increasingpopular,themajorityofFCMexperimentsarestill
being analyzed visually, usually by serial inspection of one or
two dimensions at a time. In order to improve and validate
automated gating, it is important to compare automated
gates to manual gates obtained by an expert. Gosink et al.
introduceaBioconductorpackagecalledﬂowFlowJothatcan
import gates deﬁned by the commercial package FlowJo and
work with them in a manner consistent with the other ﬂow
packages in Bioconductor. This work facilitates examination
of gating robustness, allows one to combine manual and
automated gating, and can be used to perform exploratory
data analysis on manual gates.
Another major goal in clinical applications is the identi-
ﬁcation of biological changes (e.g., proportion of cells within
a subpopulation) that correlate with a disease in order to
predict the status (e.g., healthy/diseased) of a patient. Rogers
and Holyst present ﬂowFP, a Bioconductor package for
ﬁngerprinting ﬂow cytometric data. ﬂowFP provides tools to
transform raw FCM data into a form suitable for direct input
into conventional statistical analysis and empirical modeling
software tools (e.g., supervised classiﬁcation). Among other
things ﬂowFP is based on a multivariate binning approach
and thus can bypass the gating stage, which can be an
advantage for complex ﬂow data.
In a similar clinical context, Eliot et al. investigate the use
of tree-based methods for discovering associations between
ﬂow cytometry data and clinical endpoints. In particular,
they compare a number of tree-based methods for their
capability to select immunological predictors of CD4 recon-
stitution in HIV-infected subjects initiating anti-retroviral
treatment. The authors show that tree-based methods can be
successfully applied to ﬂow cytometry data to better inform
and discover associations that may not emerge in the context
of a standard univariate analysis.
Even though Bioconductor is a great platform for FCM
allowing computational statisticians and bioinformaticians
to leverage the power of R and other contributed packages,
i tc a nr e m a i nd i ﬃcult to be used by biologists and clinicians.
Leeetal.havedevelopedanopensource,extensiblegraphical
user interface (GUI) iFlow, which sits on top of the
Bioconductor backbone, enabling basic analyses by means
of convenient graphical menus and wizards. iFlow is easily
extensible in order to quickly integrate novel methodological
developments.
Finally, Strain et al. introduce plateCore, a new package
that extends the functionality of core FCM Bioconductor
packages to enable automated negative control-based gating
and facilitate the processing and analysis of plate-based data
sets from high-throughput FCM screening experiments.
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